Reply to letter to the editor: It is not yet proven that xanomeline-trospium chloride is effective in the treatment of schizophrenia.

IF 3.7 2区医学 Q1 PSYCHIATRY

Journal of psychiatric research Pub Date : 2025-04-22 DOI:10.1016/j.jpsychires.2025.04.040

Artur Menegaz de Almeida, Fernanda Moraes Tamashiro, Maria Eduarda Cavalcanti Souza, Iasmin Isabelli Luiz Silvério, Celso de Almeida Souza Miranda, Ítalo Barros Andrade, Michele Kreuz, Francisco Cezar Aquino de Moraes, Francinny Alves Kelly

引用次数: 0

查看原文本刊更多论文

给编辑的回信：尚不能证明氯异丙胺-trospium对治疗精神分裂症有效。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of psychiatric research 医学-精神病学

CiteScore

7.30

自引率

2.10%

发文量

622

审稿时长

130 days

期刊介绍： Founded in 1961 to report on the latest work in psychiatry and cognate disciplines, the Journal of Psychiatric Research is dedicated to innovative and timely studies of four important areas of research: (1) clinical studies of all disciplines relating to psychiatric illness, as well as normal human behaviour, including biochemical, physiological, genetic, environmental, social, psychological and epidemiological factors; (2) basic studies pertaining to psychiatry in such fields as neuropsychopharmacology, neuroendocrinology, electrophysiology, genetics, experimental psychology and epidemiology; (3) the growing application of clinical laboratory techniques in psychiatry, including imagery and spectroscopy of the brain, molecular biology and computer sciences;